Cemiplimab (anti-PD-1)
Product Specifications
CAS Number
1801342-60-8
Synonyms
REGN-2810, cemiplimab-rwlc
SKU
C00022-1mg
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cemiplimab (anti-PD-1) is an intravenous human monoclonal antibody directed against programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2) . Cemiplimab blocks T-cell inactivation and enhances the immune system's anti-tumor response.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA723064B 100 µL
Human CCL23 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
BNCB1812-100 1x 100 µL
MART-1 / Melan-A / MLANA (Melanoma Marker) (rMLANA/788), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details